GMED Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
789.6M
+3.9%
759.9M
-8.1%
826.4M
+7.5%
769.0M
+3.2%
745.3M
Cost of Revenue
241.4M
+3.1%
234.1M
-10.4%
261.1M
+3.4%
252.5M
+1.5%
248.8M
Gross Profit
548.2M
+4.3%
525.8M
-7.0%
565.3M
+9.4%
516.5M
+4.0%
496.6M
Operating Expenses
365.7M
-2.6%
375.4M
-5.2%
396.0M
+4.4%
379.2M
-9.8%
420.5M
R&D
36.3M
-0.5%
36.5M
+1.0%
36.2M
-5.0%
38.1M
-4.7%
40.0M
SG&A
286.8M
-3.7%
297.8M
-6.5%
318.5M
+1.6%
313.6M
+3.3%
303.6M
Operating Income
182.4M
+21.3%
150.4M
-11.2%
169.3M
+23.3%
137.4M
+80.5%
76.1M
EBITDA
265.0M
+14.3%
231.8M
-7.4%
250.3M
+21.4%
206.1M
+6.6%
193.4M
Net Income
151.6M
+21.9%
124.3M
-11.6%
140.6M
+18.2%
119.0M
-41.4%
202.8M
EPS (Basic)
$1.12
+21.7%
$0.92
-12.4%
$1.05
+19.3%
$0.88
-41.3%
$1.50
EPS (Diluted)
$1.10
+22.2%
$0.90
-12.6%
$1.03
+17.0%
$0.88
-40.9%
$1.49
Shares (Diluted)
137.4M
-0.6%
138.2M
+1.2%
136.6M
+0.9%
135.4M
-0.8%
136.5M
GLOBUS MEDICAL (GMED) โ€” Financials